Home Biotech Stocks

Biotech Stocks

7 days popular

Teva Pharmaceutical Industries (NYSE:TEVA) Executive Yitzhak Peterburg Claims Health Care Industry...

ME Contributor - June 30, 2017

Novartis AG (ADR) (NYSE:NVS)’ Leukemia Drug Allowed Priority Review By The...

Andy Parker - March 31, 2017

AbbVie Inc (NYSE:ABBV) In Share Buyback Plan For The Third Year...

ME Contributor - February 21, 2017

Cannabis Space Continues to Shine As Latest IPO Therapix BioSciences (NASDAQ:TRPX)...

ME Contributor - March 22, 2017

VBL Therapeutics CEO tells us about their revolutionary approach to cure...

David Rich - September 16, 2016

Looking At Dynavax Technologies Corporation (NASDAQ:DVAX)’s Upcoming Hep B Catalysts

ME Contributor - August 8, 2016

Cerulean Pharma Inc (NASDAQ:CERU): What’s Next?

ME Contributor - August 19, 2016

Don’t Write Off Aradigm Corporation (NASDAQ:ARDM) Just Yet

ME Contributor - December 2, 2016

Cabiralizumab From Five Prime Therapeutics Inc (NASDAQ:FPRX) Obtains Orphan Designation

ME Contributor - January 25, 2017

PerkinElmer, Inc. (NYSE:PKI) Next Target of Acquisition By Thermo Fisher Scientific...

Andy Parker - June 16, 2017

12 3...146 Page 1 of 146

/* */

EDITOR PICKS

Cases Mount, Plastic Bag Initiative, Mental Health Deteriorates, EU Socializes Borrowing...

July 22, 2020

Market Morning: S&P Says More Spending, Hong Kong Ping Pong, Riots,...

June 1, 2020

Market Morning: Moderna Miracle? Autos Fly On Lockdown Easing, NY Governor...

May 18, 2020

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.